The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

The following is a summary of “Prevalence, clinical features, and long-term outcome of patients with primary Sjögren’s ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

This is seismic,” said Dr. Colin Duckett, vice dean for basic and preclinical science at the Duke University School of ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

A study showed that urine alkalization therapy reduces gout flares, improves kidney health, and enhances lipid profiles in ...

Travere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.

This study presents solid evidence for distinct neurotransmitter release modalities between two subclasses of dopaminergic neurons in the olfactory bulb, highlighting an important finding that ...

The following is a summary of “Association between magnesium depletion score and prevalence of hyperuricemia in American ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.